BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25990476)

  • 1. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.
    Fotopoulou C; El-Balat A; du Bois A; Sehouli J; Harter P; Muallem MZ; Krätschell RW; Traut A; Heitz F
    Arch Gynecol Obstet; 2015 Dec; 292(6):1321-7. PubMed ID: 25990476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of para-aortic lymphadenectomy in endometrial cancer.
    AlHilli MM; Mariani A
    Int J Clin Oncol; 2013 Apr; 18(2):193-9. PubMed ID: 23412768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
    Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
    Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.
    Hareyama H; Ito K; Watanabe S; Hakoyama M; Uchida A; Oku K; Watanabe Y; Hayakashi Y; Hirayama E; Okuyama K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1577-84. PubMed ID: 23060049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
    Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
    Kikuchi A; Yanase T; Sasagawa M; Honma S
    J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
    Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
    Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
    Seagle BL; Kocherginsky M; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.